OIG Permits Medical Device Manufacturer's Cost-Sharing Subsidies for Medicare Beneficiaries in Clinical Trial | Sheppard Mullin Richter & Hampton LLP

Last month, in the last advisory opinion issued by the Office of Inspector General (“OIG”) in 2023 – Advisory Opinion No. 23-11 (the “Opinion”) – OIG “blessed” an arrangement involving...

Related Keywords

,Sheppard Mullin Richter Hampton ,Office Of Inspector ,Centers For Medicare ,Medicaid Services ,Sheppard Mullin Richter ,Inspector General ,Advisory Opinion ,Federal Anti Kickback Statute ,Beneficiary Inducements Civil Monetary Penalty ,Beneficiary Inducements ,Categoryb Investigational Device Exemption ,Institutional Review Board ,About Investigational Device Exemption ,Diversity Plans ,Improve Enrollment ,Participants From Underrepresented Racial ,Ethnic Populations ,Clinical Trials ,Federal Law ,